Diagnamed Holdings Corp. (CSE:DMED)

Canada flag Canada · Delayed Price · Currency is CAD
0.1000
+0.0050 (5.26%)
Oct 31, 2025, 9:56 AM EDT
5.26%
Market Cap10.48M
Revenue (ttm)n/a
Net Income (ttm)-1.13M
Shares Out110.28M
EPS (ttm)-0.01
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume163,667
Average Volume923,754
Open0.1000
Previous Close0.0950
Day's Range0.0950 - 0.1000
52-Week Range0.0150 - 0.1300
Beta-1.12
RSI54.68
Earnings DateJan 30, 2026

About Diagnamed Holdings

Diagnamed Holdings Corp. engages in the development and commercialization of AI healthcare solutions. It focuses on developing BRAIN AGE BRAIN HEALTH, a brain health AI platform leveraging that aims to predict and monitor brain age and provide actionable insights for mental health and neurodegenerative disorders; and CERVAI, brain health and wellness AI solution. It has a collaboration agreement with EIREX for the development and commercialization of EIREX’s novel modular carbon-free technology that extracts hydrogen from water. Diagnamed Holdi... [Read more]

Sector Healthcare
CEO John Karagiannidis
Country Canada
Stock Exchange Canadian Securities Exchange
Ticker Symbol DMED
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.